Chee Kong Choo
CIK: 0001970632
Transaction Breakdown
Open Market Buys (P)3 (100.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
GDTC
CytoMed Therapeutics Ltd
Director10% Owner
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Jul 20, 2026GDTC
CytoMed Therapeutics Ltd
Purchase(P)Direct100K shares at avg. $1.50$150K - Jul 14, 2026GDTC
CytoMed Therapeutics Ltd
Purchase(P)Direct100K shares at avg. $1.50$150K - May 13, 2026GDTC
CytoMed Therapeutics Ltd
Purchase(P)Direct112K shares at avg. $1.15$129K
1-3 of 3 transactions
About Choo Chee Kong
Choo Chee Kong (SEC CIK 0001970632) files insider reports with the SEC as Director of CytoMed Therapeutics Ltd (GDTC).
Signal8 holds 4 ownership filings by Choo Chee Kong (1 Form 3, 3 Form 4), filed between May 15, 2026 and Jul 24, 2026. Those filings report 3 transactions, from May 13, 2026 to Jul 20, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Choo Chee Kong's filings is in SINGAPORE.
Recent filings by Choo Chee Kong
Other insiders filing for CytoMed Therapeutics Ltd (GDTC)
- Toh Keng Kiat, Director
- Yew Chak Hua, Director
- Leong Mark Kei Wei, Director
- TAN YOONG YING, Chief Corporate Officer
- Goh Yvonne, Chief Financial Officer